相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains
Jinuk Kim et al.
NATURE COMMUNICATIONS (2020)
Findings as a starting point to unravel the underlying mechanisms of in vivo interactions involving Wnt10a in bone, fat and muscle
Manabu Tsukamoto et al.
BONE (2019)
New explanation for autosomal dominant high bone mass: Mutation of low density lipoprotein receptor-related protein 6
Michael P. Whyte et al.
BONE (2019)
SOST Deficiency Aggravates Osteoarthritis in Mice by Promoting Sclerosis of Subchondral Bone
Jingyu Li et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Lrp4 Mediates Bone Homeostasis and Mechanotransduction through Interaction with Sclerostin In Vivo
Whitney A. Bullock et al.
ISCIENCE (2019)
Novel familial mutation of LRP5 causing high bone mass: Genetic analysis, clinical presentation, and characterization of bone matrix mineralization
K. M. Roetzer et al.
BONE (2018)
Dampening of the bone formation response following repeat dosing with sclerostin antibody in mice is associated with up-regulation of Wnt antagonists
Gill Holdsworth et al.
BONE (2018)
Novel WNT1 mutations in children with osteogenesis imperfecta: Clinical and functional characterization
Yanqin Lu et al.
BONE (2018)
SOST/Sclerostin Improves Posttraumatic Osteoarthritis and Inhibits MMP2/3 Expression After Injury
Jiun C. Chang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Circulating levels of sclerostin are associated with cardiovascular mortality
Cristina Novo-Rodriguez et al.
PLOS ONE (2018)
The Lrp4 R1170Q Homozygous Knock-In Mouse Recapitulates the Bone Phenotype of Sclerosteosis in Humans
Eveline Boudin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2017)
ImageJ2: ImageJ for the next generation of scientific image data
Curtis T. Rueden et al.
BMC BIOINFORMATICS (2017)
Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA Pathways
Megan M. Weivoda et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
A Novel Domain-Specific Mutation in a Sclerosteosis Patient Suggests a Role of LRP4 as an Anchor for Sclerostin in Human Bone
Igor Fijalkowski et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
High-Throughput, Multi-Image Cryohistology of Mineralized Tissues
Nathaniel A. Dyment et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2016)
Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters
William R. Strohl
BIODRUGS (2015)
Combinatorial and Computational Approaches to Identify Interactions of Macrophage Colony-stimulating Factor (M-CSF) and Its Receptor c-FMS
Lior Rosenfeld et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
SOST Inhibits Prostate Cancer Invasion
Bryan D. Hudson et al.
PLOS ONE (2015)
Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption
Lei Xiong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
High levels of circulating sclerostin are associated with better cardiovascular survival in incident dialysis patients: results from the NECOSAD study
Christiane Drechsler et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Serum Sclerostin and Adverse Outcomes in Nondialyzed Chronic Kidney Disease Patients
Mehmet Kanbay et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Renal Elimination of Sclerostin Increases With Declining Kidney Function
Daniel Cejka et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
LRP4 Is Critical for Neuromuscular Junction Maintenance
Arnab Barik et al.
JOURNAL OF NEUROSCIENCE (2014)
Uremic toxicity and sclerostin in chronic kidney disease patients
Lucie Desjardins et al.
NEPHROLOGIE & THERAPEUTIQUE (2014)
LACK OF SCLEROSTIN PROMOTES OSTEOARTHRITIS BY ACTIVATING CANONICAL AND NON-CANONICAL WNT PATHWAYS
W. Bouaziz et al.
OSTEOARTHRITIS AND CARTILAGE (2014)
Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels
Ming-Kang Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
WNT1 Mutations in Families Affected by Moderately Severe and Progressive Recessive Osteogenesis Imperfecta
Shawna M. Pyott et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
Mutations in WNT1 Cause Different Forms of Bone Fragility
Katharina Keupp et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?
Liesbeth Viaene et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Missense polymorphisms of the WNT16 gene are associated with bone mass, hip geometry and fractures
C. Garcia-Ibarbia et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Mutational Analysis of Sclerostin Shows Importance of the Flexible Loop and the Cystine-Knot for Wnt-Signaling Inhibition
Verena Boschert et al.
PLOS ONE (2013)
Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study
Vincent M. Brandenburg et al.
BMC NEPHROLOGY (2013)
Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity
Johanna Korvala et al.
BMC MEDICAL GENETICS (2012)
Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading
Xiaolin Tu et al.
BONE (2012)
Both LRP5 and LRP6 Receptors Are Required to Respond to Physiological Wnt Ligands in Mammary Epithelial Cells and Fibroblasts
Shruti Goel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Characterization of the Interaction of Sclerostin with the Low Density Lipoprotein Receptor-related Protein (LRP) Family of Wnt Co-receptors
Gill Holdsworth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Meta-Analysis of Genome-Wide Scans for Total Body BMD in Children and Adults Reveals Allelic Heterogeneity and Age-Specific Effects at the WNT16 Locus
Carolina Medina-Gomez et al.
PLOS GENETICS (2012)
WNT16 Influences Bone Mineral Density, Cortical Bone Thickness, Bone Strength, and Osteoporotic Fracture Risk
Hou-Feng Zheng et al.
PLOS GENETICS (2012)
Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG)
C. M. Laine et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator Function
Olivier Leupin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis
B. Y. Chan et al.
OSTEOARTHRITIS AND CARTILAGE (2011)
Wnt Antagonists Bind through a Short Peptide to the First β-Propeller Domain of LRP5/6
Eric Bourhis et al.
STRUCTURE (2011)
Distinct Modes of Inhibition by Sclerostin on Bone Morphogenetic Protein and Wnt Signaling Pathways
Carola Krause et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Cellular and Molecular Mechanisms of Bone Remodeling
Liza J. Raggatt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Glucocorticoid-dependent Wnt signaling by mature osteoblasts is a key regulator of cranial skeletal development in mice
Hong Zhou et al.
DEVELOPMENT (2009)
Characterization of the Structural Features and Interactions of Sclerostin MOLECULAR INSIGHT INTO A KEY REGULATOR OF Wnt-MEDIATED BONE FORMATION
Vaclav Veverka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Sclerostin Mediates Bone Response to Mechanical Unloading Through Antagonizing Wnt/β-Catenin Signaling
Chuwen Lin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Building bone to reverse osteoporosis and repair fractures
Sundeep Khosla et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Initiation of Wnt signaling: control of Wnt coreceptor Lrp6 phosphorylation/activation via frizzled, dishevelled and axin functions
Xin Zeng et al.
DEVELOPMENT (2008)
A histone lysine methyltransferase activated by non- canonical Wnt signalling suppresses PPAR-γ transactivation
Ichiro Takada et al.
NATURE CELL BIOLOGY (2007)
Evolution of an interloop disulfide bond in high-affinity antibody mimics based on fibronectin type III domain and selected by yeast surface display: Molecular convergence with single-domain camelid and shark antibodies
Dasa Lipovsek et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
LRP6 mutation in a family with early coronary disease and metabolic risk factors
Arya Mani et al.
SCIENCE (2007)
LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction
Scott D. Weatherbee et al.
DEVELOPMENT (2006)
Isolating and engineering human antibodies using yeast surface display
Ginger Chao et al.
NATURE PROTOCOLS (2006)
SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor
M Semënov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling
XF Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Heterozygous mutations in the LDL receptor-related protein 5 (LRP5) gene are associated with primary osteoporosis in children
H Hartikka et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Skeletal defects in ringelschwanz mutant mice reveal that Lrp6 is required for proper somitogenesis and osteogenesis
C Kokubu et al.
DEVELOPMENT (2004)
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
DG Winkler et al.
EMBO JOURNAL (2003)
High bone density due to a mutation in LDL-receptor-related protein 5
LM Boyden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease
W Balemans et al.
JOURNAL OF MEDICAL GENETICS (2002)
Diverse roles for the LDL receptor family
DK Strickland et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2002)
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein
ME Brunkow et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
W Balemans et al.
HUMAN MOLECULAR GENETICS (2001)
Arrow encodes an LDL-receptor-related protein essential for Wingless signalling
M Wehrli et al.
NATURE (2000)
分享论文
